يعرض 1 - 10 نتائج من 38 نتيجة بحث عن '"Familial Combined"', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المصدر: Biomedicines
    Volume 8
    Issue 1
    Biomedicines, Vol 8, Iss 1, p 6 (2020)
    Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona

    وصف الملف: application/pdf

  4. 4
  5. 5
    دورية أكاديمية
  6. 6
    تقرير

    المصدر: Effects of Activation of the Farnesoid X Receptor (FXR) on Hepatic Lipid and Glucose Metabolism in Patients With the Metabolic Syndrome and Familial Forms of Hypertriglyceridemia

  7. 7
    تقرير

    المصدر: Farnr M, Freeman MW, Macdonell G, Perevozskaya Davs MJ, Mchel YB, Gumber B; Ezete Study Group. Effacy and safety of the coadmtratn of ezete wh fenofrate patnts wh med hyperlaem. Eur Heart J. 2005 May;26(9):897-905. do 10.1093/eurheartj/eh31. Epub 2005 Mar 21.
    Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia

  8. 8
    تقرير

    المصدر: Farnr M, Freeman MW, Macdonell G, Perevozskaya Davs MJ, Mchel YB, Gumber B; Ezete Study Group. Effacy and safety of the coadmtratn of ezete wh fenofrate patnts wh med hyperlaem. Eur Heart J. 2005 May;26(9):897-905. do 10.1093/eurheartj/eh31. Epub 2005 Mar 21.
    McKenney JM, Farnr M, Lo KW, Bays HE, Perevozkaya Carlson G, Davs MJ, Mchel YB, Gumber B. Safety and effacy of long-term co-admtratn of fenofrate and ezete patnts wh med hyperlem. J Am Coll Cardl. 2006 Apr 18;47(8):1584-7. do 10.1016/j.jacc.2005.11.072. Epub 2006 Mar 30.
    Trble DL, Farnr M, Macdonell G, Perevozskaya Davs MJ, Gumber B, Musler TA. Effects of fenofrate and ezete, both as monotherapy and coadmtratn, on cholesterol mass wh loprote subfractns and low-densy loprote peak partle se patnts wh med hyperlem. Metabolm. 2008 Jun;57(6):796-801. do 10.1016/j.metabol.2008.01.026.
    Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia

  9. 9
    تقرير

    المصدر: Farnr M, Roth E, G-Extremera B, Mendez GF, Macdonell G, Haml C, Perevozskaya Davs MJ, Kush D, Mchel YB; Ezete/Svastat + Fenofrate Study Group. Effacy and safety of the coadmtratn of ezete/svastat wh fenofrate patnts wh med hyperlem. Am Heart J. 2007 Feb;153(2):335.e1-8. do 10.1016/j.ahj.2006.10.031.
    Farnr M, Perevozskaya Taggart WV, Kush D, Mchel YB. VAP analys of loprote subclasses med hyperlem patnts on treatment wh ezete/svastat and fenofrate. J L Res. 2008 Dec;49(12):2641-7. do 10.1194/jlr.P800034-JLR200. Epub 2008 Jul 31.
    G-Extremera B, Mendez G, Zakson M, Meehan A, Shah A, L J, Mchel Y. Effacy and safety of ezete/svastat co- admtered wh fenofrate med hyperlem patnts wh metabol syndrome. Metab Syndr Relat Dord. 2007 Dec;5(4):305-14. do 10.1089/met.2007.0011.
    A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia

  10. 10
    تقرير

    المصدر: A Double-blind, Double Dummy, Phase IV, Randomized, Multicenter, Parallel Group, Placebo Controlled Trial to Evaluate the Effect of Rosuvastatin on Triglycerides Levels in Mexican Hypertriglyceridemic Patients